Pain Management Devices Market Forecast By Top Leading Players | Medtronic, Boston Scientific

1
Pain Management Devices Market is set to be
driven by the increasing incidence of Sports
Injuries and Cancer
2
Pain is an unpleasant sensation and emotional
experience usually caused by tissue damage. Pain
can be either acute or chronic. According to the
2019 National Health Interview Survey, more than
7 United States adults had chronic pain
syndrome, which limited their ability to perform
out normal tasks at work. The Global Pain
Management Devices Market is expected to grow at
a rate of 9 to reach 3.5 billion by 2026.
Rising cases of chronic pain-inducing diseases
(like diabetes, muscoskeletal disorders),
increased geriatric population, favorable
reimbursement scenario for spinal cord
stimulation (SCS) devices in developed countries,
rising RD investment, increasing incidence of
sports injuries and cancer, and growing demand
for chronic pain management in home care
treatment are some of the main factors driving
the global pain management devices
market. Advent of Advanced Pain Management
Technologies Drives the Pain Management Devices
Market At the moment, oral medications are the
primary line of treatment for pain management
since they are easily available and less
expensive. The quality of treatment and care,
however, has greatly improved in recent years as
a result of the development of advanced
technologies, FDA-approved non-prescription
medical devices, devices used in combination with
prescription medications, or other kinds of pain
management therapy.
3

• Spinal cord stimulators, transcutaneous
  electrical nerve stimulation devices, analgesic
  infusion pumps, and ablation devices are numerous
  types of pain management devices available in the
  market.
• Numerous advancements have recently been
  developed to improve the quality of life for
  people suffering from chronic pain, including
• In October 2021, SPR Therapeutics secured 37M VP
  funding to scale operations for Sprint pain
  relief device
• In August 2020, Medtronic launched its
  FDA-approved neurostimulator, called the
  InterStim Micro Neurostimulator which helps
  patients to effective control bladder and bowel
  movement
• Explore Premium Report on Pain Management Devices
  Market _at_ https//meditechinsights.com/pain-managem
  ent-devices-market/
• Key Challenges/ Constraints Pain Management
  Devices Market
• Patients with chronic pain who are no longer
  responding to drug therapy usually turn to pain
  management devices as a second line of treatment.
  Hypersensitivity reactions and post-operative
  infections caused due to the use of these devices
  are likely to hamper growth of the pain
  management devices market.

4
North America Leads in terms of Adoption of Pain
Management Devices Market With a gt50 market
share, North America dominates the market for
pain management devices, followed by Europe and
Asia Pacific. Some of the major factors
influencing the market growth include the need
for drug-free therapies, the availability of
well-planned reimbursement and insurance
coverage, and the presence of major players in
this region. Competitive Landscape Analysis of
Pain Management Devices Market The global pain
management devices market is marked by presence
of established key players such as Medtronic,
Boston Scientific, Abbott, BD, Baxter
International, Stryker, Smiths Medical, Nipro
Corporation, Nevro Corp., Mindray
Microtransponder, among others. For More
Detailed Insights, Contact Us _at_ https//meditechin
sights.com/contact-us/ About Medi-Tech
Insights Medi-Tech Insights is a
healthcare-focused business research insights
firm. Our clients include Fortune 500 companies,
blue-chip investors hyper-growth start-ups. We
have completed 100 projects in Digital Health,
Healthcare IT, Medical Technology, Medical
Devices Pharma Services. Contact Ruta
Halde Associate, Medi-Tech Insights 32 498 86 80
79 info_at_meditechinsights.com